» Authors » Rafaela Cavalheiro do Espirito Santo

Rafaela Cavalheiro do Espirito Santo

Explore the profile of Rafaela Cavalheiro do Espirito Santo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 55
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marques C, Pinheiro M, Lopes J, Ribeiro S, de Castro M, de Azevedo Valadares L, et al.
Adv Rheumatol . 2025 Jan; 65(1):4. PMID: 39844312
Objectives: To compare the impact of COVID-19 on the clinical status and psychological distress of patients with immune-mediated rheumatic disease (IMRD) caused by SARS-CoV-2 infection with that of noninfected IMRD...
2.
do Espirito Santo R, Melo G, Dubey V, Agostinis-Sobrinho C
Nutr Metab Cardiovasc Dis . 2024 Dec; :103778. PMID: 39643478
Background And Aims: Previous studies have investigated the concordance between objective and subjective measures for assessing physical activity, sedentary behaviour, and sleep duration separately. However, no studies have compared adherence...
3.
da Rosa T, Bartikoski B, do Espirito Santo R, Farinon M, de Souza Silva J, Pedo R, et al.
Adv Rheumatol . 2024 Nov; 64(1):85. PMID: 39538350
Background: Sarcopenia is a muscle disease characterized by reduction of muscle strength and muscle mass. In RA, 25.9 to 43.3% of the patients present sarcopenia. The loss of muscle mass...
4.
do Espirito Santo R, Melo G, Dubey V, Jankauskiene R, Baceviciene M, Agostinis-Sobrinho C
BMJ Open Sport Exerc Med . 2024 Oct; 10(4):e002191. PMID: 39430401
The 24-hour Movement Behaviour (24-h MovBeh) paradigm, encompassing physical activity (PA), sedentary behaviour (SB) and sleep patterns, is recognised as a holistic approach to adolescent health. It emphasises promoting PA,...
5.
do Espirito Santo R, Dos Santos L, Melo G, Dubey V, Rauckiene-Michaelsson A, Agostinis-Sobrinho C
J Am Med Dir Assoc . 2024 Oct; 25(12):105293. PMID: 39366668
Objectives: Patients with immune-mediated rheumatic diseases (IMRDs) often exhibit reduced muscle strength. Therefore, this review aimed to evaluate muscle strength in patients with IMRDs compared with healthy control and to...
6.
Calderaro D, Valim V, Ferreira G, Machado K, Ribeiro P, Ribeiro S, et al.
Vaccines (Basel) . 2024 Sep; 12(9). PMID: 39340061
Breakthrough COVID-19 (occurring in fully vaccinated people) has been described. Data on its characteristics among immune-mediated rheumatic disease (IMRD) patients are scarce. This study describes breakthrough COVID-19 occurring in IMRD...
7.
Oliveira Nunes Teixeira V, Bartikoski B, do Espirito Santo R, Alabarse P, Ghannan K, Silva J, et al.
Adv Rheumatol . 2023 Mar; 63(1):14. PMID: 36949513
Background: Rheumatoid arthritis is an autoimmune inflammatory disease that often leads patients to muscle impairment and physical disability. This study aimed to evaluate changes in the activity of proteasome system...
8.
Pena E, Dos Santos L, do Espirito Santo R, Guaresi S, Hirakata V, Karnopp T, et al.
Clin Rheumatol . 2023 Feb; 42(5):1237-1248. PMID: 36790643
To perform a systematic review with meta-analysis to verify muscle strength, muscle mass, and physical function of patients with systemic lupus erythematosus (SLE) and compare then with healthy individuals and...
9.
do Espirito Santo R, Baker J, Dos Santos L, de Souza Silva J, Filippin L, Portes J, et al.
PLoS One . 2023 Jan; 18(1):e0280846. PMID: 36689423
Introduction: Self-reported disability is potentially influenced by many factors in patients with rheumatoid arthritis (RA). In this sense, we evaluated the association between self-reported disability and (1) clinical features, (2)...
10.
Dalmolin S, Pedo R, da Rosa T, de Souza Silva J, Farinon M, Gasparini M, et al.
Adv Rheumatol . 2022 Nov; 62(1):43. PMID: 36371346
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial inflammation, fibroblast-like synoviocytes (FLS) activation and joint destruction. Fasciola hepatica is a platyhelminth that releases excretory-secretory immunomodulatory products...